Clinical Trial Update: Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast Cancer [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 neoadjuvant trial evaluating chemotherapy in combination with Celecoxib for invasive breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Celecoxib (Celecoxib)
• Chemotherapy (chemotherapy)

Snippet

Sponsor: Organisation for Oncology and Translational Research | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED